A shares express delivery at the opening bell | Low opening and high closing! Shanghai index turns red in midday trading, large consumer sector rebounds.
On the market, pharmaceuticals and liquor sectors are showing strength.
On April 3, the A-share market opened lower and went higher, with the Shanghai Composite Index turning red mid-day and nearly 3100 stocks rising. As of 9:46, the Shanghai Composite Index was up 0.02%, the Shenzhen Component Index was down 0.73%, and the Growth Enterprise Market Index was down 0.65%.
In terms of the market, pharmaceutical stocks performed well, with Beijing Science Sun Pharmaceutical, Harbin Medisan Pharmaceutical, Zhuhai Rundu Pharmaceutical and others hitting the limit up; the consumer sector rebounded, with sectors such as animal husbandry and liquor showing strength, with Hunan Xiangjia Animal Husbandry hitting the limit up; the precious metals sector was active, with Western Region Gold leading the way. On the downside, copper cable high-speed connections, lithography machines, consumer electronics and other sectors had the largest declines.
Looking ahead, GF SEC believes that the speculative sentiment phase is fading, and the market is entering a period of seeking truth from fiction.
Popular Sectors:
1. Precious metals sector active
The precious metals sector is active, with Western Region Gold leading the way, and stocks like Beijing Xiaocheng Technology Stock, Chifeng Jilong Gold Mining, Sichuan Gold, Shandong Gold Mining all rising.
Reviewing the historical data, in April, industries that perform well tend to be those that are superior in performance, policy-oriented, and trending upwards in the industry. The styles may lean towards balance with opportunities for growth, consumption, and cyclical sectors. Pharmaceuticals are strong, with stocks like Beijing Science Sun Pharmaceutical, Harbin Medisan Pharmaceutical, and Zhuhai Rundu Pharmaceutical hitting the limit up.
Regarding the institution's viewpoint, GF SEC believes that the emotional stage of "speculation on expectations" is receding and the market is entering a phase of seeking the truth.
2. Pharmaceutical sector strong
Pharmaceutical stocks are active, with Beijing Science Sun Pharmaceutical, Harbin Medisan Pharmaceutical, Zhuhai Rundu Pharmaceutical hitting the limit up.
Institution's viewpoints:
1. Huajin Securities: April's fundamentals dominate, continue to oscillate
Huajin Securities pointed out that the A-share market may continue its oscillating trend in April, with little possibility of big gains or losses. Growth, consumption, and cyclical sectors may all have opportunities for allocation. Looking back at history, in April, industries that are superior in performance, policy-oriented, and trending upwards tend to perform better. In summary, the market is expected to continue its volatility with opportunities for allocation in sectors like technology, cyclical, and others.
2. GF SEC: The emotion of the speculative stage is fading, the market is entering a window of seeking truth
GF SEC indicated that April is historically the month with the most trading of fundamentals in A-shares, and the second and third quarters are the most efficient time windows for investment. This means that the market will gradually shift from "speculating on expectations" to focusing on performance, with a higher emphasis on first-quarter reports of A-share companies. Technology growth remains a key theme for the year, and opportunities for positioning continue to arise with each adjustment.
Related Articles

Zhongjin: Domestic sales of air conditioners in 1Q25 have been increasing gradually, focusing on companies that may benefit from potential stimulation of domestic demand.

Morgan Stanley is optimistic about Blackstone (BX.US) being driven by multiple sectors to navigate through bull and bear markets, and reiterates its "buy" rating.

CITIC SEC: AUSNUTRIA (01717) is expected to improve its full-year profit in 2024, and its full-year performance is expected to improve year-on-year in 2025.
Zhongjin: Domestic sales of air conditioners in 1Q25 have been increasing gradually, focusing on companies that may benefit from potential stimulation of domestic demand.

Morgan Stanley is optimistic about Blackstone (BX.US) being driven by multiple sectors to navigate through bull and bear markets, and reiterates its "buy" rating.

CITIC SEC: AUSNUTRIA (01717) is expected to improve its full-year profit in 2024, and its full-year performance is expected to improve year-on-year in 2025.

RECOMMEND6

Spokesperson of the Ministry of Commerce responds to reporters' questions on the United States' use of tariff measures to pressure other countries to restrict economic and trade cooperation with China.
21/04/2025

Wall Street identifies "tariff safe haven": Asia's essential consumer stocks.
21/04/2025

Tariffs provoke dissatisfaction among American people, Trump's approval rating on economy hits a new low.
21/04/2025